Results of arthroplasty in oncological patients with primary and metastatic bone tumours around the knee

Relevance Knee joint replacement is the main method of surgical treatment in patients with oncological lesions of the distal femur and proximal tibia. The article presents the results of the use of this technique in Herzen Moscow Research Institute for Oncology. Purpose To evaluate the results of a...

Full description

Bibliographic Details
Main Authors: Vitaly A. Derzhavin, Artem V. Bukharov, Anna V. Yadrina, Dmitry A. Erin
Format: Article
Language:English
Published: Russian Ilizarov Scientific Center for Restorative Traumatology and Orthopaedics 2020-09-01
Series:Гений oртопедии
Subjects:
id doaj-971d3600c07d4546bc18a3c0a2bf6e79
record_format Article
spelling doaj-971d3600c07d4546bc18a3c0a2bf6e792020-11-25T02:44:22ZengRussian Ilizarov Scientific Center for Restorative Traumatology and OrthopaedicsГений oртопедии1028-44272542-131X2020-09-0126334735210.18019/1028-4427-2020-26-3-347-352Results of arthroplasty in oncological patients with primary and metastatic bone tumours around the kneeVitaly A. Derzhavin0https://orcid.org/0000-0002-4385-9048Artem V. Bukharov1https://orcid.org/0000-0002-2976-8895Anna V. Yadrina2https://orcid.org/0000-0002-7944-3108Dmitry A. Erin3https://orcid.org/0000-0002-3501-036XP.A. Hertsen Moscow Oncology Research Center – branch of the NMRRC of the Ministry of Health of the Russian Federation, Moscow, Russian FederationP.A. Hertsen Moscow Oncology Research Center – branch of the NMRRC of the Ministry of Health of the Russian Federation, Moscow, Russian FederationP.A. Hertsen Moscow Oncology Research Center – branch of the NMRRC of the Ministry of Health of the Russian Federation, Moscow, Russian FederationP.A. Hertsen Moscow Oncology Research Center – branch of the NMRRC of the Ministry of Health of the Russian Federation, Moscow, Russian FederationRelevance Knee joint replacement is the main method of surgical treatment in patients with oncological lesions of the distal femur and proximal tibia. The article presents the results of the use of this technique in Herzen Moscow Research Institute for Oncology. Purpose To evaluate the results of arthroplasty in patients with tumour lesions of the distal femur and proximal tibia. Materials and methods Between 2011 and 2019, primary knee replacement due to oncology was performed in 106 patients. Distal femoral resection was performed in 70 (66 %), proximal tibia resection in 36 (34 %) patients. Primary bone tumors were detected in 70 (66 %) patients. Metastases of various solid tumors were observed in 36 (34 %) patients. Results In the group of patients with primary malignant bone tumours (49 patients), 36 (73.5 %) patients survived without signs of tumour progression, 3 (6 %) were alive with disease manifestations, 10 (20.5 %) patients died from progression. Relapse was diagnosed in 6 (12%), metastatic lung damage in 13 (26 %). All patients with a giant cell tumour survived without signs of disease progression. In the group of patients with metastatic lesions (36 patients), 25 patients (69 %) died from disease progression. The average value of the functional result on the MSTS scale was 78% for all endoprostheses. The incidence of postoperative complications was 30 %, among which the prevailing was infection (9.5 %). Conclusion The main adverse event in arthroplasty of large joints in oncologic patients remains the frequency of postoperative complications, which can develop in 20 to 30 % of the patients. Further research on the possibility of using various designs and types of implants is necessary in order to reduce the incidence of postoperative complications and improve long-term functional outcomes in such patients.bone tumorssurgical treatmentjoint arthroplasty
collection DOAJ
language English
format Article
sources DOAJ
author Vitaly A. Derzhavin
Artem V. Bukharov
Anna V. Yadrina
Dmitry A. Erin
spellingShingle Vitaly A. Derzhavin
Artem V. Bukharov
Anna V. Yadrina
Dmitry A. Erin
Results of arthroplasty in oncological patients with primary and metastatic bone tumours around the knee
Гений oртопедии
bone tumors
surgical treatment
joint arthroplasty
author_facet Vitaly A. Derzhavin
Artem V. Bukharov
Anna V. Yadrina
Dmitry A. Erin
author_sort Vitaly A. Derzhavin
title Results of arthroplasty in oncological patients with primary and metastatic bone tumours around the knee
title_short Results of arthroplasty in oncological patients with primary and metastatic bone tumours around the knee
title_full Results of arthroplasty in oncological patients with primary and metastatic bone tumours around the knee
title_fullStr Results of arthroplasty in oncological patients with primary and metastatic bone tumours around the knee
title_full_unstemmed Results of arthroplasty in oncological patients with primary and metastatic bone tumours around the knee
title_sort results of arthroplasty in oncological patients with primary and metastatic bone tumours around the knee
publisher Russian Ilizarov Scientific Center for Restorative Traumatology and Orthopaedics
series Гений oртопедии
issn 1028-4427
2542-131X
publishDate 2020-09-01
description Relevance Knee joint replacement is the main method of surgical treatment in patients with oncological lesions of the distal femur and proximal tibia. The article presents the results of the use of this technique in Herzen Moscow Research Institute for Oncology. Purpose To evaluate the results of arthroplasty in patients with tumour lesions of the distal femur and proximal tibia. Materials and methods Between 2011 and 2019, primary knee replacement due to oncology was performed in 106 patients. Distal femoral resection was performed in 70 (66 %), proximal tibia resection in 36 (34 %) patients. Primary bone tumors were detected in 70 (66 %) patients. Metastases of various solid tumors were observed in 36 (34 %) patients. Results In the group of patients with primary malignant bone tumours (49 patients), 36 (73.5 %) patients survived without signs of tumour progression, 3 (6 %) were alive with disease manifestations, 10 (20.5 %) patients died from progression. Relapse was diagnosed in 6 (12%), metastatic lung damage in 13 (26 %). All patients with a giant cell tumour survived without signs of disease progression. In the group of patients with metastatic lesions (36 patients), 25 patients (69 %) died from disease progression. The average value of the functional result on the MSTS scale was 78% for all endoprostheses. The incidence of postoperative complications was 30 %, among which the prevailing was infection (9.5 %). Conclusion The main adverse event in arthroplasty of large joints in oncologic patients remains the frequency of postoperative complications, which can develop in 20 to 30 % of the patients. Further research on the possibility of using various designs and types of implants is necessary in order to reduce the incidence of postoperative complications and improve long-term functional outcomes in such patients.
topic bone tumors
surgical treatment
joint arthroplasty
work_keys_str_mv AT vitalyaderzhavin resultsofarthroplastyinoncologicalpatientswithprimaryandmetastaticbonetumoursaroundtheknee
AT artemvbukharov resultsofarthroplastyinoncologicalpatientswithprimaryandmetastaticbonetumoursaroundtheknee
AT annavyadrina resultsofarthroplastyinoncologicalpatientswithprimaryandmetastaticbonetumoursaroundtheknee
AT dmitryaerin resultsofarthroplastyinoncologicalpatientswithprimaryandmetastaticbonetumoursaroundtheknee
_version_ 1724766215861174272